Use of oxalate deficient aspergillus niger strains for producing a polypeptide

Details for Australian Patent Application No. 2004209618 (hide)

Owner DSM IP Assets B.V.

Inventors Wenzel, Thibaut Jose; Ladriere, JeanMarc Maurice Claude; Meulenberg, Rogier

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004209618

PCT Pub. Number WO2004/070022

Priority 03100236.3 05.02.03 EP

Filing date 5 February 2004

Wipo publication date 19 August 2004

Acceptance publication date 17 April 2008

International Classifications

C12N 1/14 (2006.01) Micro-organisms, e.g. protozoa - Fungi

C12N 15/80 (2006.01) Mutation or genetic engineering - for fungi

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/070022 Priority application(s): WO2004/070022

17 April 2008 Application Accepted

  Published as AU-B-2004209618

14 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004209623-Removing contaminants from natural gas

2004209609-Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long QT syndrome